Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Parallel-Arm, Double-Blind, Placebo-Controlled Study With Open-Label Extension to Assess the Efficacy and Safety of Vatiquinone for the Treatment of Friedreich Ataxia (MOVE-FA)

NCT04577352 is registered in ClinicalTrials.gov with PTC Therapeutics as lead sponsor.

NCT NCT04577352
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04577352 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Parallel-Arm, Double-Blind, Placebo-Controlled Study With Open-Label Extension to Assess the Efficacy and Safety of Vatiquinone for the Treatment of Friedreich Ataxia (MOVE-FA)
Lead sponsor
PTC Therapeutics
Phase
Phase 2/3
Overall status
Completed
Start date
December 17, 2020
Completion date
October 2, 2023
Enrollment
146 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

friedreich ataxia